Dynamic hyperinflation after metronome-paced hyperventilation in COPD- A 2 year follow-up

Respiratory Medicine

Volumn 104, Issue 11, 2010, Pages 1700-1705

  Hannink, Jorien ^a   Lahaije, Anke ^a   Bischoff, Erik ^a   Van Helvoort, Hanneke ^a   Dekhuijzen, Richard ^a   Schermer, Tjard ^a   Heijdra, Yvonne ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

COPD; Dynamic hyperinflation; Follow up; Metronome paced hyperventilation

Indexed keywords

ADULT; AGED; ARTICLE; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; HYPERVENTILATION; INSPIRATORY CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METRONOME PACED HYPERVENTILATION; PRIORITY JOURNAL; SMOKING; TOTAL LUNG CAPACITY;

BRONCHODILATOR AGENTS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; HYPERVENTILATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING; TIME FACTORS;

EID: 77957148040     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.04.007     Document Type: Article

References (23)

1. B.R. Celli, and W. Macnee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
2. D.M. Mannino, and K.J. Davis Lung function decline and outcomes in an elderly population Thorax 61 2006 472 477
3. R.P. Young, R. Hopkins, and T.E. Eaton Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes Eur Respir J 30 2007 616 622
4. C.B. Cooper The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function Am J Med 119 2006 21 31
5. D.E. O'Donnell Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease Proc Am Thorac Soc 3 2006 180 184
6. A.F. Gelb, C.A. Gutierrez, I.M. Weisman, R. Newsom, C.F. Taylor, and N. Zamel Simplified detection of dynamic hyperinflation Chest 126 2004 1855 1860
7. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, and A. Coates Standardisation of spirometry Eur Respir J 26 2005 319 338
8. T.E. Dolmage, and R.S. Goldstein Repeatability of inspiratory capacity during incremental exercise in patients with severe COPD Chest 121 2002 708 714
9. D.G. Stubbing, L.D. Pengelly, J.L. Morse, and N.L. Jones Pulmonary mechanics during exercise in subjects with chronic airflow obstruction J Appl Physiol 49 1980 511 515
10. S. Yan, D. Kaminski, and P. Sliwinski Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 156 1997 55 59
11. A. Aliverti, and P.T. Macklem The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles J Appl Physiol 105 2008 749 751
12. D. Ofir, P. Laveneziana, K.A. Webb, Y.M. Lam, and D.E. O'Donnell Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 622 629
13. I. Vogiatzis, G. Stratakos, D. Athanasopoulos, O. Georgiadou, S. Golemati, and A. Koutsoukou Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV Eur Respir J 32 2008 42 52
14. N.G. Koulouris, P. Valta, A. Lavoie, C. Corbeil, M. Chasse, and J. Braidy A simple method to detect expiratory flow limitation during spontaneous breathing Eur Respir J 8 1995 306 313
15. D.E. O'Donnell, S.M. Revill, and K.A. Webb Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 770 777
16. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, and B. Aguilaniu Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
17. J.A. van Noord, J.L. Aumann, E. Janssens, J. Verhaert, J.J. Smeets, and A. Mueller Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD Chest 129 2006 509 517
18. A.F. Gelb, C.F. Taylor, P.A. McClean, C.M. Shinar, M.T. Rodrigues, and C.A. Gutierrez Tiotropium and simplified detection of dynamic hyperinflation Chest 131 2007 690 695
19. D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur Respir J 24 2004 86 94
20. D.E. O'Donnell, A.L. Hamilton, and K.A. Webb Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD J Appl Physiol 101 2006 1025 1035
21. D.E. O'Donnell, and K.A. Webb Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation Am Rev Respir Dis 148 1993 1351 1357
22. B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, and P.W. Jones Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 2008 332 338
23. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554